ALVOAlvotech
$5.79-27% 1Y
$5.79
$3.0052 weeks$8.98
What is the market doing?
Mixed
1 good, 1 neutral, 1 without dataNo clear lean: nothing decisive, though in an uptrend.
TrendUptrendderived · Oct 9, 2026
In an uptrend, above its rising 50- and 200-day averages. Price is +34% vs its 200-day average.
Short interest1.9% of sharesFINRA · Sep 15, 2026
Lightly shorted, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How ALVO is trading
Alvotech is −27% over the past year while the S&P 500 is +18%: 45 points behind the market.
−27%
1-year return · S&P 500 +18%
- vs 200-day average
- +34%
vs 200-day average · a clear uptrend
- RSI (14)
- 48
RSI (14) · neutral
- Below its 52-week high
- 36%
Below its 52-week high
Details›
- Last close2026-10-09
- $5.79
- 1 monthS&P 500 +2.7%
- +10%
- 1 yearS&P 500 +18%
- −27%
- vs 50-day average$4.94
- +17%
- 52-week high
- $8.98
- 52-week low
- $3.00
- Annualised volatility
- 65%
| Year | Return |
|---|---|
| 2026 (year to date) | +13% |
| 2025 | −61% |
| 2024 | +15% |
| 2023 | +15% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 4 | 3 of 4 | +15% |
| Feb | 4 | 1 of 4 | −5.8% |
| Mar | 4 | 0 of 4 | −14% |
| Apr | 4 | 1 of 4 | −6.7% |
| May | 4 | 2 of 4 | +7.1% |
| Jun | 4 | 1 of 4 | −9.3% |
| Jul | 5 | 1 of 5 | +1.7% |
| Aug | 5 | 3 of 5 | +14% |
| Sep | 5 | 3 of 5 | −3.5% |
| Oct | 5 | 1 of 5 | −1.8% |
| Nov | 4 | 2 of 4 | −8.6% |
| Dec | 4 | 4 of 4 | +23% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers, Specialty & Generic
Ranks #26 of 41 by RyuScore